That's good buying. I exited at 34.5, took $12k. Had no intention to but DT dictated this.Nothing has changed, I'm looking for re-entry.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%